Title:
ガンおよび他の疾患を治療するための新規化合物
Document Type and Number:
Japanese Patent JP6549544
Kind Code:
B2
Abstract:
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, CNS, melanoma, renal, cervical, esophageal, testicular, spleenic, kidney, lymphatic, pancreatic, stomach and thyroid cancers. This invention is an anti adhesion therapy which uses the compound as a mediator or inhibitor of adhesion proteins and angiopoietins. It inhibits excess adhesion and inhibits cell attachment. It modulates angiogenesis. The compounds also use as mediator of cell adhesion receptor, cell circulating, cell moving and inflammatory diseases.
More Like This:
Inventors:
Chang, Pui-Kwon
Mac, mason
Mac, mason
Application Number:
JP2016195788A
Publication Date:
July 24, 2019
Filing Date:
October 03, 2016
Export Citation:
Assignee:
Pacific Arrow Limited
International Classes:
C07J63/00; A61K31/22; A61P1/00; A61P1/02; A61P1/04; A61P3/10; A61P5/10; A61P5/38; A61P7/02; A61P9/02; A61P9/12; A61P11/06; A61P13/02; A61P13/12; A61P19/02; A61P19/08; A61P21/00; A61P25/00; A61P25/04; A61P25/16; A61P25/18; A61P25/28; A61P29/00; A61P31/10; A61P31/12; A61P31/22; A61P35/00; A61P35/02; A61P35/04; A61P43/00
Domestic Patent References:
| JP6019021B2 |
Foreign References:
| US20070161580 | ||||
| US20090156515 | ||||
| WO2009117196A1 |
Other References:
G. Wulff, et al.,Tetrahedron,1969年,Vol.25, No.2,pp.415-436
Attorney, Agent or Firm:
Hiroe Associates Patent Office